Skip to main content
The BMJ logoLink to The BMJ
. 1992 Sep 5;305(6853):563. doi: 10.1136/bmj.305.6853.563

Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery.

S W Atkinson 1, Y Young 1, G A Trotter 1
PMCID: PMC1883303  PMID: 1393038

Full text

PDF

Page 563

563

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980 Jan;17(1):51–57. doi: 10.1007/BF00561677. [DOI] [PubMed] [Google Scholar]
  2. Pollack M. M., Dunbar B. S., Holbrook P. R., Fields A. I. Aspiration of activated charcoal and gastric contents. Ann Emerg Med. 1981 Oct;10(10):528–529. doi: 10.1016/s0196-0644(81)80009-1. [DOI] [PubMed] [Google Scholar]
  3. Pond S. M. Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol. 1986 Jan-Feb;1(1):3–11. doi: 10.1007/BF03259824. [DOI] [PubMed] [Google Scholar]
  4. Watson W. A., Cremer K. F., Chapman J. A. Gastrointestinal obstruction associated with multiple-dose activated charcoal. J Emerg Med. 1986;4(5):401–407. doi: 10.1016/0736-4679(86)90219-2. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES